Thank you! We will get back to you shortly.

Future of Liquid Biopsy for Precision Oncology Summit


Date: 21st September, 2022
Time - 1500 hrs BST /1000 hrs ET


Overview for Future of Liquid Biopsy for Precision Oncology Summit

Liquid biopsy is a non-invasive diagnostic tool that uses circulating tumor DNA (ctDNA), circulating tumor cells, or other tumor-derived components in blood plasma to determine cancer genetic status. Though liquid biopsy's minimal invasiveness and temporal resolution are appealing, the small quantity of ctDNA in plasma creates difficulty.

Liquid biopsies can assist doctors in early cancer detection and stratification, real-time monitoring of therapy response and resistance mechanisms in the tumor, assessing the likelihood of metastatic relapse, and predicting the outcome.

Cancer therapy might be controlled by liquid biopsies. They might also be the optimal scheme for precision medicine in therapy personalization. It is the most cutting-edge approach in the field of medical oncology. It has tremendous potential as a tool for cancer screening and early detection, as well as the ability to analyze a patient's state after diagnosis and recurrence, and the efficacy of real-time therapy in various cancer kinds. The limitations of tissue biopsies can be solved by liquid biopsy. Circulating tumor cells, circulating tumor nucleic acids, free of cells or enclosed in exosomes, microvesicles, and platelets make up the liquid biopsy. Liquid biopsy investigations are done on a variety of biofluids retrieved in a non-invasive manner, including blood, urine, saliva, and cerebrospinal fluid.

Group Futurista is excited to announce the “Future of Liquid Biopsy for Precision Oncology” Summit.

You can grab your passes for free!

What to Expect?


Connect, listen and learn with our live digital sessions.

Panel Discussions

Conversations and deliberations that are contagious


Network Digitally with industry leaders across the globe

Virtual one to one

Effective one-on-one meetings are a powerful tool to connect and close the deals with your leads.

Summit Highlights

07+ Knowledge Sessions

The summit will consist of interesting web panel discussions, exclusive live fireside chats and engaging digital industry presentations. 

10+ Industry

Industry's thought leaders, decision-makers, and solution providers will gather virtually to discuss the latest trends, innovations, and technologies in the Artificial Intelligence Industry.


Congregation of industry's top-level executives and senior officials for knowledge sharing.

Discussion Points

NGS Library Prep: Automating and Optimizing.

Next generation sequencing of SARS-CoV-2 genomes: challenges, applications and opportunities.

Molecular profiling for precision cancer therapies.

Common applications of next-generation sequencing technologies in genomic research.

Who should attend?

Topic We Cover

Liquid Biopsy

Developmental & Commercialization Pathways

Bioanalytical methods

Metastatic cells

Radiographic imaging

Long Reads & Genome Structure

Single Cell Sequencing

Spatial Sequencing Technologies

Population Scale And Clinical Sequencing

Technology Trends

Genetic Sequencing

Development Of Companion Diagnostics

Personalized Medicine

NGS-Based Surveillance

Targeted Gene Expression Profiling

Large Whole-Genome Sequencing

Small Whole-Genome Sequencing

Single-Cell Profiling



Cell-Free Sequencing & Liquid Biopsy Analysis




Hospital & Healthcare

Diagnostic centres

Digital Health

Job Titles

CXO, VP, Director, Head, Manager & Specialist of -

  • Oncology
  • Sterile Liquid Oncology
  • Solid Oncology
  • AVP, Oncology and Genomics
  • Scientist (Molecular Virology & Next Generation Sequencing)
  • Next Generation Sequencing Specialist
  • Senior Scientist Next Generation Sequencing Initiatives
  • Genetic Technologist - Next Generation Sequencing
  • Clinical Next Generation Sequencing
  • Digital Health
  • Bioinformatics
  • Precision Medicine
  • Cancer Genomics Tech- Next Generation Sequencing
  • Bioinformatic Data Engineer
  • Biomedical Scientist
  • Nanopore Sequencing
  • Genomic Medicine
  • Translational Medicine
  • IT Early Solutions
  • Immuno-Oncology & Biomarker
  • Computational Biology and Data Sciences
  • Scientific Officer & Director of Operations
  • Genomics R&D



Frequently asked question

Absolutely. We are counting on you to invite others! Help us spread the word. You can simply share the link to this page, and they can register at their convenience.